Semaglutide
Semaglutide Savings Programs in Canada
Canadian manufacturer patient support programs are not the same thing as a US-style copay card. Here is what genuinely lowers your semaglutide cost in Canada, and what to be skeptical of.
Quick verdict
Canada does not have a widely available semaglutide "savings card" in the US sense of an instant point-of-sale discount. The tactics that actually reduce cost here are provincial or private insurance coverage, coordination of benefits between the two, whatever a manufacturer's patient support program can help with for paperwork and access, and the federal Medical Expense Tax Credit. Stack the ones you qualify for rather than searching for a single discount card.
Canadian programs vs US copay cards
In the United States, manufacturer copay cards are built around the US commercial insurance system: they apply a set discount at the pharmacy counter for eligible insured patients, and the mechanics are fairly uniform brand to brand. Canada's public and private insurance landscape does not run on the same rails, and Canadian manufacturer support offerings are typically structured as patient support programs rather than a point-of-sale card. These programs generally focus on helping you navigate insurance requirements, prior authorization forms, and general access questions for a specific branded product, not on issuing a guaranteed dollar-value discount to any purchaser. If a site or pharmacy tells you a specific savings card exists, confirm the details directly with your pharmacy or the manufacturer's own patient support page before counting on it.
Coverage stacking tactics
Rather than one savings mechanism, most people who reduce their semaglutide cost meaningfully do it by combining a few of the levers below.
| Tactic | How it helps |
|---|---|
| Provincial formulary coverage | Special Authority or Limited Use approval for an eligible diagnosis can cut your cost to a co-pay plus dispensing fee. |
| Private or workplace plan | Many plans cover one or more semaglutide products, sometimes after prior authorization; check your formulary. |
| Coordination of benefits | A private plan may cover part of what a provincial plan does not, reducing your remaining out-of-pocket share. |
| Manufacturer patient support program | Typically helps with insurance navigation and paperwork for a specific branded product, not a flat point-of-sale discount. |
| Medical Expense Tax Credit | Out-of-pocket spending on an authorized semaglutide product may count toward the federal credit at tax time. |
Compare online providers
Some licensed Canadian providers include help with insurance paperwork and prior authorization as part of their program, which functions like an informal cost-reduction tactic even when it is not labeled a savings card. Compare current, provider-reported program pricing below. A clinician still makes the independent decision on whether semaglutide is right for you.
| Provider | Monthly program cost | Consultation fee | Coverage | Learn more |
|---|---|---|---|---|
| MyRockyTop pick | From ~$149/mo for generic semaglutide; brand-name Ozempic ~$200-$420/mo and Mounjaro (tirzepatide) ~$350-$630/mo, depending on dose | One-time $99 consultation, covering the full clinical assessment, lab review, and first prescription if eligible | All 10 provinces | Visit MyRocky |
| Felix | From $149/mo for generic semaglutide; brand-name Ozempic about $220 to $250/mo, with Wegovy and Saxenda priced by dose | One-time $99 consultation, covering the clinical assessment and first prescription if eligible | Most provinces | Visit Felix |
How patient support programs work
Manufacturer-run patient support programs vary by product and change over time, so this page does not name a specific program or promise a specific dollar amount. What is consistent is the general shape: these programs typically assist with insurance navigation, paperwork for Special Authority or prior authorization requests, and general education about the medication. They are usually tied to the specific branded product, so switching to a generic version from a different manufacturer can mean the program no longer applies to you. Ask your prescribing clinician or pharmacist what, if anything, currently applies to your prescription.
Medical Expense Tax Credit
Money you pay out of pocket for an authorized semaglutide product, whether brand, generic, or the oral tablet, may count toward the federal Medical Expense Tax Credit alongside your other eligible medical expenses for the year. Keep every pharmacy receipt, and ask a tax professional whether your total eligible expenses clear the threshold that applies to your income.
Prescription notice
Advertising disclosure
Frequently asked questions
- Is there a semaglutide savings card in Canada like the ones in the US?
- Not in the same form. US manufacturer copay cards typically apply a fixed discount directly at checkout for commercially insured patients, a structure built around the US pharmacy benefit system. Canadian manufacturer patient support programs work differently and generally focus on helping patients navigate insurance coverage, prior authorization paperwork, and access rather than a flat point-of-sale discount. Ask your prescriber or pharmacist what support program, if any, applies to the specific product you are prescribed.
- What is a patient support program and how do I find out if one applies to me?
- A patient support program is typically run by or on behalf of the manufacturer to help patients navigate insurance, paperwork, and access questions for a specific brand-name product. Availability and what the program actually offers change over time, so ask your prescribing clinician or pharmacist directly rather than assuming a program exists or matches what you have seen advertised elsewhere.
- Can I combine provincial coverage with private insurance for semaglutide?
- In many cases, yes. If a provincial plan covers part of the cost, a private plan may cover some or all of the remaining co-payment, depending on how your private plan coordinates benefits with public coverage. Check with your private insurer about coordination of benefits rules before assuming full stacking is automatic.
- Does switching to generic semaglutide affect my access to a savings or support program?
- Possibly. Manufacturer patient support programs are usually tied to the manufacturer's own branded product, so switching to a generic from a different manufacturer may mean that specific program no longer applies. Weigh the generic's lower list price against whatever support the brand program offers before switching.
- Are there other ways to reduce cost besides a manufacturer program?
- Yes. Comparing pharmacy dispensing fees, asking about generic availability, checking your Special Authority or Limited Use eligibility under your provincial formulary, and reviewing your private plan's co-pay structure often move the needle more than a single savings program. The Medical Expense Tax Credit is also worth claiming on out-of-pocket spending.
- Should I be cautious of websites advertising a specific semaglutide savings card?
- Yes. Treat any site promising a guaranteed dollar-value discount or a card that works like a US copay card with caution, since that structure does not reliably exist for Canadian pharmacy purchases. Confirm any program directly with your pharmacy, your prescriber, or the manufacturer's own official patient support page before relying on it.
Sources and related reading
This guide references Health Canada drug decision summaries and Canada's Drug Agency reimbursement reviews. Pharmacy and program figures are indicative, so confirm current details with your pharmacy, prescriber, or provider.
References and further reading
- Canada's Drug Agency (CDA-AMC), semaglutide reimbursement review (Canada's Drug Agency). Reimbursement, coverage, and cost-effectiveness review.
- Diabetes Canada, Pharmacologic Glycemic Management guidelines (Diabetes Canada). How GLP-1 medicines fit into Canadian diabetes care.
- Health Canada, Ozempic Summary Basis of Decision (Health Canada). Canadian approval of semaglutide for type 2 diabetes.
- Health Canada, Wegovy Regulatory Decision Summary (Health Canada). Canadian approval of semaglutide 2.4 mg for chronic weight management.
Explore Online Weight-Management Care in Canada
Complete a short eligibility assessment and connect with a licensed Canadian provider.